Covered recipient · General Payments record
REBECCA JOE RENN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$1,053.57
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $399.57 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $148.32 | 12 |
| Lundbeck LLC | $78.71 | 3 |
| Otsuka America Pharmaceutical, Inc. | $52.06 | 2 |
| Janssen Pharmaceuticals, Inc | $35.60 | 1 |
| Alkermes, Inc. | $26.16 | 1 |
| Vanda Pharmaceuticals Inc. | $24.26 | 1 |
| Teva Pharmaceuticals USA, Inc. | $20.60 | 1 |
| ITI, Inc. | $13.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.20 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105937870 | CMS |
| ABBVIE INC. | $22.88 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105937872 | CMS |
| ABBVIE INC. | $10.92 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105937874 | CMS |
| ABBVIE INC. | $29.86 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105937876 | CMS |
| ABBVIE INC. | $7.61 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105937878 | CMS |
| ABBVIE INC. | $10.62 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105937880 | CMS |
| ABBVIE INC. | $6.71 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105937882 | CMS |
| ABBVIE INC. | $8.49 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105937884 | CMS |
| ABBVIE INC. | $11.35 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105937886 | CMS |
| ABBVIE INC. | $9.50 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105937888 | CMS |
| ABBVIE INC. | $6.18 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105937890 | CMS |
| ABBVIE INC. | $11.00 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105937892 | CMS |
| Alkermes, Inc. | $26.16 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120580067 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13.86 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143305608 | CMS |
| Janssen Pharmaceuticals, Inc | $35.60 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078245451 | CMS |
| Lundbeck LLC | $28.18 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145960670 | CMS |
| Lundbeck LLC | $24.36 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145960672 | CMS |
| Lundbeck LLC | $26.17 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145960674 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.92 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118968563 | CMS |
| Otsuka America Pharmaceutical, Inc. | $33.14 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118968565 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.60 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151619291 | CMS |
| Vanda Pharmaceuticals Inc. | $24.26 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133917841 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.